장내 대장암 유발 효소인 베타글루쿠로니다아제 및 트립토파나아제의 활성을 저해하는 조성물 및 대장암 예방 조성물
    2.
    发明公开
    장내 대장암 유발 효소인 베타글루쿠로니다아제 및 트립토파나아제의 활성을 저해하는 조성물 및 대장암 예방 조성물 有权
    用于抑制与大肠癌和抗癌组合物相关的β-GLUCURONIDASE和TRYPTOPHANASE的组合物

    公开(公告)号:KR1020100051277A

    公开(公告)日:2010-05-17

    申请号:KR1020080110363

    申请日:2008-11-07

    Abstract: PURPOSE: An activity inhibition composition and a prevention composition of a colon cancer using a mycelium or its extract of a ganoderma lucidum are provided to control the activity of beta-glucuronidase and tryptophanase. CONSTITUTION: An activity inhibition composition contains a mycelium or its extract of a ganoderma lucidum as an active ingredient. The mycelium of the ganoderma lucidum is a ganoderma lucidum KCTC 16806. The activity inhibition composition for controlling the activity of beta-glucuronidase contains uracil ribonucleoside separated from the dried mycelium of the ganoderma lucidum as the active ingredient. A prevention composition of a colon cancer also contains the uracil ribonucleoside.

    Abstract translation: 目的:提供使用菌丝体或其灵芝提取物的活性抑制组合物和结肠癌的预防组合物以控制β-葡糖苷酸酶和色氨酸酶的活性。 构成:活性抑制组合物含有灵芝的菌丝体或其提取物作为活性成分。 灵芝的菌丝体是灵芝KCTC16806。用于控制β-葡糖苷酸酶活性的活性抑制组合物含有从灵芝的干燥菌丝体中分离出的尿嘧啶核糖核苷作为活性成分。 结肠癌的预防组合物也含有尿嘧啶核糖核苷。

Patent Agency Ranking